Myeloid derived suppressor cells are present at high frequency in neonates and suppress in vitro t cell responses

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Gervassi, Ana ^a   Lejarcegui, Nicholas ^a   Dross, Sandra ^a,b   Jacobson, Amanda ^a   Itaya, Grace ^a   Kidzeru, Elvis ^c   Gantt, Soren ^d   Jaspan, Heather ^b,c   Horton, Helen ^a,b  

^a SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ARTICLE; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CELL ISOLATION; CELLULAR IMMUNITY; CHILD; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; GRANULOCYTE; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; INFANT; INFECTION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MORTALITY; MYELOID DERIVED SUPPRESSOR CELL; NEWBORN; PHENOTYPE; PRESCHOOL CHILD; SUPPRESSOR CELL; VACCINATION; ADULT; CELL CULTURE; CYTOLOGY; FETUS BLOOD; IMMUNOLOGY; METABOLISM;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; FETAL BLOOD; GRANULOCYTES; HUMANS; IN VITRO TECHNIQUES; INFANT; INFANT, NEWBORN; INTERFERON-GAMMA; MYELOID CELLS;

EID: 84907584310     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107816     Document Type: Article

References (61)

1. WHO (2012) Child Mortality Report. World Health Organization, Geneva, Switzerland.
2. Wood N, Siegrist CA (2011) Neonatal immunization: where do we stand? Curr Opin Infect Dis 24: 190-195.
3. PrabhuDas M, Adkins B, Gans H, King C, Levy O, et al. (2011) Challenges in infant immunity: implications for responses to infection and vaccines. Nat Immunol 12: 189-194.
4. Hodgins DC, Shewen PE (2012) Vaccination of neonates: problem and issues. Vaccine 30: 1541-1559.
5. Marodi L (2006) Neonatal innate immunity to infectious agents. Infect Immun 74: 1999-2006.
6. B. Lewis DB, Wilson CB (2006) Developmental immunology and role of host defenses in fetal and neonatal susceptibility to infection. In: Remington JS, Klein JO, Wilson CB, Baker CJ, editors. Infectious Diseases of the Fetus and Newborn Infant, 6th ed. Philadelphia: Elsevier Saunders. pp. 87-210.
7. Poschke I, Kiessling R (2012) On the armament and appearances of human myeloid-derived suppressor cells. Clin Immunol 144: 250-268.
8. Gabrilovich DI, Ostrand-Rosenberg S, Bronte V (2012) Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 12: 253-268.
9. Ostrand-Rosenberg S, Sinha P, Beury DW, Clements VK (2012) Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression. Semin Cancer Biol 22: 275-281.
10. Gabrilovich DI, Bronte V, Chen SH, Colombo MP, Ochoa A, et al. (2007) The terminology issue for myeloid-derived suppressor cells. Cancer Res 67: 425; author reply 426.
11. Makrigiannakis A, Karamouti M, Drakakis P, Loutradis D, Antsaklis A (2008) Fetomaternal immunotolerance. Am J Reprod Immunol 60: 482-496.
12. Makrigiannakis A, Petsas G, Toth B, Relakis K, Jeschke U (2011) Recent advances in understanding immunology of reproductive failure. J Reprod Immunol 90: 96-104.
13. Bansal AS (2010) Joining the immunological dots in recurrent miscarriage. Am J Reprod Immunol 64: 307-315.
14. Rieber N, Gille C, Kostlin N, Schafer I, Spring B, et al. (2013) Neutrophilic myeloid-derived suppressor cells in cord blood modulate innate and adaptive immune responses. Clin Exp Immunol 174: 45-52.
15. Pillay J, Tak T, Kamp VM, Koenderman L (2013) Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences. Cell Mol Life Sci 70(20): 3813-3827.
16. Brandau S, Moses K, Lang S (2013) The kinship of neutrophils and granulocytic myeloid-derived suppressor cells in cancer: Cousins, siblings or twins? Semin Cancer Biol 23: 171-182.
17. Dumitru CA, Lang S, Brandau S (2013) Modulation of neutrophil granulocytes in the tumor microenvironment: Mechanisms and consequences for tumor progression. Semin Cancer Biol 23: 141-148.
18. Fridlender ZG, Sun J, Mishalian I, Singhal S, Cheng G, et al. (2012) Transcriptomic analysis comparing tumor-associated neutrophils with granulocytic myeloid-derived suppressor cells and normal neutrophils. PLoS One 7: e31524.
19. Kotsakis A, Harasymczuk M, Schilling B, Georgoulias V, Argiris A, et al. (2012) Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples. J Immunol Methods 381: 14-22.
20. Horton H, Frank I, Baydo R, Jalbert E, Penn J, et al. (2006) Preservation of T cell proliferation restricted by protective HLA alleles is critical for immune control of HIV-1 infection. J Immunol 177: 7406-7415.
21. Horton H, Havenar-Daughton C, Lee D, Moore E, Cao J, et al. (2006) Induction of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses in HIV vaccine trial participants who subsequently acquire HIV-1 infection. J Virol 80: 9779-9788.
22. Montero AJ, Diaz-Montero CM, Kyriakopoulos CE, Bronte V, Mandruzzato S (2012) Myeloid-derived suppressor cells in cancer patients: a clinical perspective. J Immunother 35: 107-115.
23. Liu CY, Wang YM, Wang CL, Feng PH, Ko HW, et al. (2010) Population alterations of L-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14(-)/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer. J Cancer Res Clin Oncol 136: 35-45.
24. Mundy-Bosse BL, Young GS, Bauer T, Binkley E, Bloomston M, et al. (2011) Distinct myeloid suppressor cell subsets correlate with plasma IL-6 and IL-10 and reduced interferon-alpha signaling in CD4(+) T cells from patients with GI malignancy. Cancer Immunol Immunother 60: 1269-1279.
25. Raychaudhuri B, Rayman P, Ireland J, Ko J, Rini B, et al. (2011) Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma. Neuro Oncol 13: 591-599.
26. Rodriguez PC, Ernstoff MS, Hernandez C, Atkins M, Zabaleta J, et al. (2009) Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res 69: 1553-1560.
27. Romero R, Espinoza J, Goncalves LF, Kusanovic JP, Friel LA, et al. (2006) Inflammation in preterm and term labour and delivery. Semin Fetal Neonatal Med 11: 317-326.
28. Blois SM, Ilarregui JM, Tometten M, Garcia M, Orsal AS, et al. (2007) A pivotal role for galectin-1 in fetomaternal tolerance. Nat Med 13: 1450-1457.
29. D'Addio F, Riella LV, Mfarrej BG, Chabtini L, Adams LT, et al. (2011) The link between the PDL1 costimulatory pathway and Th17 in fetomaternal tolerance. J Immunol 187: 4530-4541.
30. Somerset DA, Zheng Y, Kilby MD, Sansom DM, Drayson MT (2004) Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset. Immunology 112: 38-43.
31. Sasaki Y, Sakai M, Miyazaki S, Higuma S, Shiozaki A, et al. (2004) Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol Hum Reprod 10: 347-353.
32. Godfrey WR, Spoden DJ, Ge YG, Baker SR, Liu B, et al. (2005) Cord blood CD4(+)CD25(+)-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function. Blood 105: 750-758.
33. Fu B, Li X, Sun R, Tong X, Ling B, et al. (2013) Natural killer cells promote immune tolerance by regulating inflammatory TH17 cells at the human maternal-fetal interface. Proc Natl Acad Sci U S A 110: E231-240.
34. Chabtini L, Mfarrej B, Mounayar M, Zhu B, Batal I, et al. (2013) TIM-3 regulates innate immune cells to induce fetomaternal tolerance. J Immunol 190: 88-96.
35. Mold JE, Venkatasubrahmanyam S, Burt TD, Michaelsson J, Rivera JM, et al. (2010) Fetal and adult hematopoietic stem cells give rise to distinct T cell lineages in humans. Science 330: 1695-1699.
36. Lo YM, Lo ES, Watson N, Noakes L, Sargent IL, et al. (1996) Two-way cell traffic between mother and fetus: biologic and clinical implications. Blood 88: 4390-4395.
37. Takahata Y, Nomura A, Takada H, Ohga S, Furuno K, et al. (2004) CD25+ CD4+ T cells in human cord blood: an immunoregulatory subset with naive phenotype and specific expression of forkhead box p3 (Foxp3) gene. Exp Hematol 32: 622-629.
38. Elahi S, Ertelt JM, Kinder JM, Jiang TT, Zhang X, et al. (2013) Immunosuppressive CD71+ erythroid cells compromise neonatal host defence against infection. Nature 504: 158-162.
39. Orlikowsky TW, Spring B, Dannecker GE, Niethammer D, Poets CF, et al. (2003) Expression and regulation of B7 family molecules on macrophages (MPhi) in preterm and term neonatal cord blood and peripheral blood of adults. Cytometry B Clin Cytom 53: 40-47.
40. Kollmann TR, Crabtree J, Rein-Weston A, Blimkie D, Thommai F, et al. (2009) Neonatal innate TLR-mediated responses are distinct from those of adults. J Immunol 183: 7150-7160.
41. Midthun K, Halsey NA, Jett-Goheen M, Clements ML, Steinhoff M, et al. (1991) Safety and immunogenicity of human rotavirus vaccine strain M37 in adults, children, and infants. J Infect Dis 164: 792-796.
42. Vekemans J, Ota MO, Wang EC, Kidd M, Borysiewicz LK, et al. (2002) T cell responses to vaccines in infants: defective IFNgamma production after oral polio vaccination. Clin Exp Immunol 127: 495-498.
43. Gans HA, Yasukawa LL, Zhang CZ, Wakim RH, Rinki M, et al. (2008) Effects of interleukin-12 and interleukin-15 on measles-specific T-cell responses in vaccinated infants. Viral Immunol 21: 163-172.
44. Ota MO, Vekemans J, Schlegel-Haueter SE, Fielding K, Whittle H, et al. (2004) Hepatitis B immunisation induces higher antibody and memory Th2 responses in new-borns than in adults. Vaccine 22: 511-519.
45. Sharma SK, Pichichero ME (2012) Functional deficits of pertussis-specific CD4+ T cells in infants compared to adults following DTaP vaccination. Clin Exp Immunol 169: 281-291.
46. Rowe J, Macaubas C, Monger T, Holt BJ, Harvey J, et al. (2001) Heterogeneity in diphtheria-tetanus-acellular pertussis vaccine-specific cellular immunity during infancy: relationship to variations in the kinetics of postnatal maturation of systemic th1 function. J Infect Dis 184: 80-88.
47. Clerici M, DePalma L, Roilides E, Baker R, Shearer GM (1993) Analysis of T helper and antigen-presenting cell functions in cord blood and peripheral blood leukocytes from healthy children of different ages. J Clin Invest 91: 2829-2836.
48. Marodi L (2006) Innate cellular immune responses in newborns. Clin Immunol 118: 137-144.
49. Hong EH, Chang SY, Lee BR, Pyun AR, Kim JW, et al. (2013) Intratumoral injection of attenuated Salmonella vaccine can induce tumor microenvironmental shift from immune suppressive to immunogenic. Vaccine 31: 1377-1384.
50. Morales JK, Kmieciak M, Graham L, Feldmesser M, Bear HD, et al. (2009) Adoptive transfer of HER2/neu-specific T cells expanded with alternating gamma chain cytokines mediate tumor regression when combined with the depletion of myeloid-derived suppressor cells. Cancer Immunol Immunother 58: 941-953.
51. Iclozan C, Antonia S, Chiappori A, Chen DT, Gabrilovich D (2013) Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer. Cancer Immunol Immunother 62: 909-918.
52. Roth F, De La Fuente AC, Vella JL, Zoso A, Inverardi L, et al. (2012) Aptamer-mediated blockade of IL4Ralpha triggers apoptosis of MDSCs and limits tumor progression. Cancer Res 72: 1373-1383.
53. Apetoh L, Vegran F, Ladoire S, Ghiringhelli F (2011) Restoration of antitumor immunity through selective inhibition of myeloid derived suppressor cells by anticancer therapies. Curr Mol Med 11: 365-372.
54. Vincent J, Mignot G, Chalmin F, Ladoire S, Bruchard M, et al. (2010) 5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity. Cancer Res 70: 3052-3061.
55. Le HK, Graham L, Cha E, Morales JK, Manjili MH, et al. (2009) Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice. Int Immunopharmacol 9: 900-909.
56. Srivastava MK, Dubinett S, Sharma S (2012) Targeting MDSCs enhance therapeutic vaccination responses against lung cancer. Oncoimmunology 1: 1650-1651.
57. Najjar YG, Finke JH (2013) Clinical perspectives on targeting of myeloid derived suppressor cells in the treatment of cancer. Front Oncol 3: 49.
58. Yang WC, Ma G, Chen SH, Pan PY (2013) Polarization and reprogramming of myeloid-derived suppressor cells. J Mol Cell Biol 5: 207-209.
59. Greten TF, Manns MP, Korangy F (2011) Myeloid derived suppressor cells in human diseases. Int Immunopharmacol 11: 802-807.
60. Lalor MK, Floyd S, Gorak-Stolinska P, Weir RE, Blitz R, et al. (2011) BCG vaccination: a role for vitamin D? PLoS One 6: e16709.
61. Villamor E, Fawzi WW (2005) Effects of vitamin a supplementation on immune responses and correlation with clinical outcomes. Clin Microbiol Rev 18: 446-464.